Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2021 10:15 ET | Source: Conversion Labs, Inc.

Conversion Labs Appoints Digital Marketing Executive, Bryant Hussey, as Chief Digital Officer

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed digital marketing expert and industry thought-leader,...
December 15, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Annualized Revenue Run-Rate Hits $53.9 Million, up 332% vs. 2019, Driven by Subscriptions to an Expanding Suite of Telehealth Brands

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, reported its annualized revenue run-rate reached a record...
December 11, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Launches Veritas MD™ Telehealth Platform, Delivering Greater Access to Growing Portfolio of Industry-Leading, Direct-to-Consumer Pharmacy and Wellness Brands

NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its new Veritas MD telehealth...
December 09, 2020 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Approved for Nasdaq Capital Market Listing; Trading to Commence Tomorrow, December 10, 2020, Under the Symbol, CVLB

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the Nasdaq Capital...
November 20, 2020 07:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Appoints Expert Life Sciences Attorney, Eric H. Yecies, as Chief Compliance Officer and General Counsel

NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed expert Life Sciences attorney, Eric H....
November 16, 2020 16:01 ET | Source: Conversion Labs, Inc.

Conversion Labs Q3 2020 Revenue up 252% to Record $11.0 Million

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, reported results for the third quarter and...
November 10, 2020 07:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Appoints WEX CFO and Former Revlon CFO, Roberto Simon, to Board of Directors

NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has appointed Roberto Simon to its board of...
November 09, 2020 13:00 ET | Source: Conversion Labs, Inc.

Conversion Labs to Host Third Quarter Conference Call on Monday, November 16, 2020 at 4:30 p.m. ET

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday,...
November 04, 2020 09:00 ET | Source: Conversion Labs, Inc.

Conversion Labs Closes Initial Round of $15 Million Private Placement with Institutional Investors, Advances Toward Nasdaq Uplisting

NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 million of a...
October 26, 2020 07:35 ET | Source: Conversion Labs, Inc.

Conversion Labs Licenses Restorsea Technology Platform for Launch of New Teledermatology Line, Nava MD™

NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has signed a licensing agreement with...